Drug intelligence / Profile preview

hesperetin

Development stage
Phase 1
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Hesperetin is a naturally occurring flavanone found predominantly in citrus fruits as the aglycone of the glycoside hesperidin. It exhibits cholesterol-lowering, antioxidant, anti-inflammatory, anti-allergic, hypolipidemic, vasoprotective and anticarcinogenic properties[1][5][6]. Mechanistically, hesperetin inhibits acyl-coenzyme A:cholesterol acyltransferase (ACAT1 and ACAT2) and microsomal triglyceride transfer protein (MTP), while upregulating LDL receptor expression. This results in reduced assembly/secretion of apoB-containing lipoproteins and enhanced reuptake of these lipoproteins by cells—ultimately lowering cholesterol levels[1][3]. Hesperetin also modulates oxidative stress pathways (e.g., Nrf2), neuroinflammation (NF-kB), mitochondrial apoptosis signaling in neurodegenerative disease models such as Parkinson’s disease and epilepsy[5], and can induce apoptosis via ROS generation in cancer cell lines[6]. It is under investigation for cardiovascular health support and potential neuroprotective effects.

Other names
4'-methoxy-eriodictyol3',5,7-trihydroxy-4'-methoxyflavanone
02

Targets

ACAT1 (Acyl-coenzyme A:cholesterol O-acyltransferase 1)SOAT2 (Acyl-coenzyme A:cholesterol acyltransferase 2)LDLR (Low-density lipoprotein receptor)MTTP (Microsomal triglyceride transfer protein large subunit)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NF-κB

Beyond the preview

Go deeper on hesperetin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hesperetin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call